# Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis

> **NCT06731101** · NA · COMPLETED · sponsor: **Fayoum University** · enrollment: 46 (actual)

## Conditions studied

- Palmar Hyperhidrosis

## Interventions

- **DRUG:** Bupivacaine + Lidocaine +dexamethasone
- **DRUG:** Tryptizole + Librax

## Key facts

- **NCT ID:** NCT06731101
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-15
- **Primary completion:** 2025-12-10
- **Final completion:** 2026-01-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731101, "Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06731101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*